Title of article
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial
Author/Authors
Bengt I Eriksson، نويسنده , , Ola E Dahl، نويسنده , , Nadia Rosencher، نويسنده , , Andreas A Kurth، نويسنده , , C. Niek van Dijk، نويسنده , , Simon P. Frostick، نويسنده , , Martin H. Prins، نويسنده , , Rohan Hettiarachchi، نويسنده , , Stefan Hantel، نويسنده , , Janet Schnee، نويسنده , , Harry R. Büller، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
8
From page
949
To page
956
Abstract
Background
After hip replacement surgery, prophylaxis following discharge from hospital is recommended to reduce the risk of venous thromboembolism. Our aim was to assess the oral, direct thrombin inhibitor dabigatran etexilate for such prophylaxis.
Metho
Journal title
The Lancet
Serial Year
2008
Journal title
The Lancet
Record number
591914
Link To Document